119th Congress Taxation
H.R. 1414: Cameron’s Law
Introduced
- Introduced (completed)
- Passed House (not reached)
- Passed Senate (not reached)
- To the President (not reached)
- Became law (not reached)
Summary
This bill increases the orphan drug tax credit to 50% (from 25%) of qualified clinical testing expenses paid or incurred in the development of drugs to treat certain rare diseases or conditions.
As background, the Tax Cuts and Jobs Act reduced the orphan drug tax credit (for tax years after 2017) to 25% of qualified clinical testing expenses (e.g., wages, supplies, and certain contract expenses) paid or incurred in the development of drugs to treat certain rare diseases or conditions. For 2017 and prior tax years, the orphan tax credit was 50% of such expenses paid or incurred.
Written by the Congressional Research Service, Library of Congress.
Roll calls
No roll call votes have been held on this bill.
Amendments
No amendments were offered to this bill.
Cosponsors
- Don Bacon R-NEOriginal
- Jimmy Panetta D-CAOriginal
- Thomas Suozzi D-NYOriginal
- Max Miller R-OH
- Brian Fitzpatrick R-PA
- Mike Carey R-OH
- Henry Johnson D-GA
- Donald Davis D-NC
- Michael Lawler R-NY
- Henry Cuellar D-TX
- Bradley Schneider D-IL
- Jim Costa D-CA
- Young Kim R-CA
- Mike Kelly R-PA
- André Carson D-IN
- Claudia Tenney R-NY
- Jennifer Kiggans R-VA
- Thomas Kean R-NJ
- Jeff Hurd R-CO
Who scored on this bill
- 1Josh Gottheimer SponsorDrew cross-party cosponsors, introduced2 events+6
See all scorers and every scoring event
Introductions and cosponsorships count toward weekly caps and show no points.
Other bills by Josh Gottheimer
History
- Introduced in the House by Josh Gottheimer.
Show the full action history (2 actions)
- Introduced in House
- Referred to the House Committee on Ways and Means.